CSL Limited (OTCMKTS:CSLLY – Get Free Report) shares shot up 0.2% during mid-day trading on Friday . The company traded as high as $91.91 and last traded at $91.19. 32,278 shares traded hands during mid-day trading, a decline of 13% from the average session volume of 37,233 shares. The stock had previously closed at $91.05.
CSL Price Performance
The firm has a 50-day simple moving average of $91.65 and a 200 day simple moving average of $90.20.
CSL Company Profile
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Featured Stories
- Five stocks we like better than CSL
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Roth IRA Calculator: Calculate Your Potential Returns
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Are Penny Stocks a Good Fit for Your Portfolio?
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.
